project id: TCGA-LUAD; case submitter id: TCGA-75-7025; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.0; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 3305.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; alcohol history: Not Reported; years smoked: 19.0; is ffpe: false; weight: 23.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.5; longest dimension: 0.6; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-75-7025-01A-12; percent necrosis: 2.0; percent normal cells: 5.0; percent stromal cells: 15.0; percent tumor cells: 78.0; percent tumor nuclei: 80.0;